| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |